Polyclonal Antibody to Actin Alpha 2, Smooth Muscle (ACTa2)
| Code | Size | Price |
|---|
| PAB342Mi01-20ul | 20ul | £89.00 |
Quantity:
| PAB342Mi01-100ul | 100ul | £169.00 |
Quantity:
| PAB342Mi01-200ul | 200ul | £228.00 |
Quantity:
| PAB342Mi01-1ml | 1ml | £523.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species:
- Bovine (Cattle)
- Cavia (Guinea pig)
- Chicken (Gallus)
- Equine (Horse)
- Human
- Mouse
- Rat
- Rhesus Macaque
- Sheep
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
ACT-A2; ACTSA; ACTVS; Asma; GIG46; Cell growth-inhibiting gene 46 protein
Buffer Formulation:
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Item Name:
Actin Alpha 2, Smooth Muscle
Reactivity:
Hu;Mu;Ra;Gu;Rb;Si;Po;Bo;Eq;Ga;
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.5-5ug/mL;<br/>Immunohistochemistry: 5-20ug/mL;<br/>Immunocytochemistry: 5-20ug/mL;<br/>Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Actin Alpha 2, Smooth Muscle (ACTa2) | RPB342Mi01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||